Navigation Links
Pharmacyclics Reports Financial Results and Recent Developments for Fiscal Year and Fourth Quarter 2011 - Conference Call Set for Today at 4:30 PM EDT
Date:9/12/2011

res is provided below.

About PharmacyclicsPharmacyclics® is a clinical-stage biopharmaceutical company focused on developing and commercializing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases. Our mission and goal is to build a viable biopharmaceutical company that designs, develops and commercializes novel therapies intended to improve quality of life, increase duration of life and resolve serious unmet medial healthcare needs; and to identify promising product candidates based on scientific development expertise, develop our products in a rapid, cost-efficient manner and pursue commercialization and/or development partners when and where appropriate.

Presently, Pharmacyclics has three product candidates in clinical development and several preclinical molecules in lead optimization. We are committed to high standards of ethics, scientific rigor, and operational efficiency as we move each of these programs to viable commercialization.

The Company is headquartered in Sunnyvale, California and is listed on NASDAQ under the symbol PCYC. To learn more about how Pharmacyclics advances science to improve human healthcare visit us at http://www.pharmacyclics.com.

NOTE: This announcement may contain forward-looking statements made in reliance upon the safe harbor provisions of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements regarding our expectations and beliefs regarding our future results or performance. Because these statements apply to future events, they are subject to risks and uncertainties. When used in this announcement, the words "anticipate", "believe", "estimate", "expect", "expectation", "should", "would", "project", "plan", "predict", "intend" and similar expressions are intended to identify such forward-looking statements. Our actual res
'/>"/>

SOURCE Pharmacyclics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Pharmacyclics Announces Date of Fiscal Year End 2011 Financial Results and Conference Call
2. Pharmacyclics Reports Recent Developments From Clinical Studies of its Btk Inhibitor PCI-32765
3. Pharmacyclics Announces Oral Presentations and Clinical Update at Upcoming Medical Meetings
4. Pharmacyclics to Announce Third Quarter Fiscal 2011 Results and Host a Conference Call on May 4, 2011
5. Pharmacyclics to Announce Second Quarter Fiscal 2011 Results and Host a Conference Call on February 4, 2011
6. Pharmacyclics Reports Updated Clinical Results from its Phase IA Trial of its First in Human Btk-Inhibitor PCI-32765
7. Pharmacyclics Reports CLL Results from Preclinical and Clinical Studies of its Btk Inhibitor PCI-32765
8. Pharmacyclics Reports Financial Results for Fiscal 2010 and for Fourth Quarter 2010
9. Pharmacyclics Announces Date of Fiscal Year End 2010 Financial Results and Conference Call and Presentation at Stifel Nicolaus Healthcare Conference
10. Pharmacyclics to Present at Bank of America Merrill Lynch Healthcare Conference and MDB Bright Lights Conference
11. Pharmacyclics to Present at the RBC Capital Markets Healthcare Investor Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... 19, 2014  Monarch America Inc. (OTCQB: CANK) ("Monarch ... pleased to provide this review of the Company,s recent ... "Over this past year, we achieved many ... extremely proud to say that Monarch America is in ... has ever been," stated Eric Hagen , CEO ...
(Date:12/19/2014)... , December 18, 2014 ... software application/module that is used to store, manipulate, ... RIS comprises a patient tracking and scheduling system, ... integration of RIS with HIS and other databases ... patient registration and patient scheduling, patient list management, ...
(Date:12/19/2014)... 18, 2014 Research and Markets ... the "Micro Market Monitor: North American Dermatology ... http://photos.prnewswire.com/prnh/20130307/600769 ... steadily, which has resulted in fueling the overall ... main purpose of these dermatology devices is to ...
Breaking Medicine Technology:Monarch America Inc. CEO Reviews Recent Achievements and Provides Outlook for 2015 2Monarch America Inc. CEO Reviews Recent Achievements and Provides Outlook for 2015 3The Global Radiology Information Systems Market is Expected to Grow at a CAGR of 7.5% from 2014 to 2019 2The Global Radiology Information Systems Market is Expected to Grow at a CAGR of 7.5% from 2014 to 2019 3Micro Market Monitor: North American Dermatology Diagnostic Devices Market 2Micro Market Monitor: North American Dermatology Diagnostic Devices Market 3
... Feb. 4, 2011 Novo Nordisk announced today ... mobile application (app) to assist in the diagnosis ... Craig Kessler, MD, Professor of Medicine and Pathology ... Hospital, Lombardi Comprehensive Cancer Center. Coags Uncomplicated features ...
... or "Company") (Nasdaq: UNIS ; ASX: UNS) announced ... the fiscal 2011 second quarter ended December 31, 2010 after ... Management has scheduled a conference call for 4:30 p.m. ... February 15 at 8:30 a.m. AEDT) , to review the ...
Cached Medicine Technology:Novo Nordisk Creates First Mobile Application to Help Doctors Diagnose Bleeding Disorders 2Unilife Corporation to Announce Financial Results for Fiscal 2011 Second Quarter on Monday, February 14, 2011 2
(Date:12/19/2014)... (PRWEB) December 19, 2014 ... dedicated to developing educational events, tools and resources ... Rouxbe Cooking School , the world’s leading online ... prescription every human being needs: Culinary Rx. As ... cooking course, Culinary Rx, scheduled for debut spring ...
(Date:12/19/2014)... CA (PRWEB) December 19, 2014 SuperCloset ... 5x5 SuperClone Rooms. SuperCloset continues to offer indoor growers ... Pair one of the new SuperClone Rooms with the ... perpetual, and turnkey indoor hydroponic grow room setup. , ... the world, SuperCloset’s SuperPonic SuperCloner 50 . ...
(Date:12/19/2014)... Albany, NY (PRWEB) December 20, 2014 ... Africa, Russia, and other nations. Around 151,000 tons of ... on year. The global vanadium usage increased at 6.7% ... which, the steel and iron industry, being the largest ... industry in 2013, followed by titanium-vanadium alloy and the ...
(Date:12/19/2014)... TX (PRWEB) December 20, 2014 The ... a new injectable filler from respected cosmetic brand Juvéderm. ... occur naturally with age. The Medspa at Hendrick is ... development in skin care technology to its clients. , ... gel to be FDA-approved to treat the mid-face and ...
(Date:12/19/2014)... warns parents that buying an older car for their teens may ... drivers killed in the United States between 2008 and 2012 were ... lacked important safety features that are available on newer cars, the ... were in cars at least six years old, 34 percent were ... cars 11 to 15 years old, and 17 percent were in ...
Breaking Medicine News(10 mins):Health News:The Plantrician Project and the Rouxbe Cooking School Join Forces to Develop Culinary Rx – a Plant-Prescription Course 2Health News:The Plantrician Project and the Rouxbe Cooking School Join Forces to Develop Culinary Rx – a Plant-Prescription Course 3Health News:The Plantrician Project and the Rouxbe Cooking School Join Forces to Develop Culinary Rx – a Plant-Prescription Course 4Health News:SuperCloset Continues to Innovate with New Complete Indoor Grow Room Packages, The SuperClone Rooms are the Newest Addition to the Award Winning SuperRoom Lineup 2Health News:Marketresearchreports.biz: Global Vanadium Usage Increased at AAGR of 6.7% between 2001 and 2013 2Health News:Marketresearchreports.biz: Global Vanadium Usage Increased at AAGR of 6.7% between 2001 and 2013 3Health News:Breakthrough New Injectable Dermal Filler Voluma XC Offered by The MedSpa at Hendrick 2Health News:Older Cars a Bad Choice for Younger Drivers 2
... Outside Board Meeting, MARTINEZ, Calif., Nov. 26 ... place outside Tuesday,s meeting of the Contra,Costa Board ... The 150,000-member SEIU United Healthcare Workers-West is ... United States and represents,every type of healthcare worker, ...
... cholera, a potentially fatal,diarrheal disease found in the ... orally vaccinating half of the affected,populations once every ... to,new findings by an international team of researchers ... in the Vaccine and Infectious Disease,Institute at Fred ...
... experience stigma, loneliness and ostracism, and can find it ... new research findings. , They also struggle to ... though, in theory, there is 100% access to state-funded ... result. , Sarah Bernays, of the London School of ...
... 26 The Wackenhut,Corporation, the leading security services ... to enhance its employee medical and dental,insurance plans ... further validation that Wackenhut,s focus on employee welfare ... consulting firm, Mercer, released an overview of,its most ...
... ... Marine Underwriters, CANTON, Mass., Nov. 26 ... Southern Marine,& Aviation Inc., to represent its International Marine Underwriters (IMU),division. ... under a primary marine cargo program managed by Southern Marine &,Aviation, ...
... Datascope Urges Shareholders to Re-Elect Incumbent Directors and Reject ... ... Datascope Corp.,(Nasdaq: DSCP ) today filed an investor ... available on the Investor,Relations section of the Company,s website at ...
Cached Medicine News:Health News:Study Shows Cholera Can be Controlled With Oral Vaccines 2Health News:Study Shows Cholera Can be Controlled With Oral Vaccines 3Health News:New study highlights stigma and stress of living with HIV/AIDS in Serbia 2Health News:New study highlights stigma and stress of living with HIV/AIDS in Serbia 3Health News:Wackenhut Enhances Health Insurance Plans Without Raising Costs 2Health News:OneBeacon Appoints Southern Marine & Aviation Inc. 2Health News:OneBeacon Appoints Southern Marine & Aviation Inc. 3Health News:OneBeacon Appoints Southern Marine & Aviation Inc. 4Health News:Datascope Files Investor Presentation 2Health News:Datascope Files Investor Presentation 3Health News:Datascope Files Investor Presentation 4Health News:Datascope Files Investor Presentation 5Health News:Datascope Files Investor Presentation 6Health News:Datascope Files Investor Presentation 7Health News:Datascope Files Investor Presentation 8
Digital Ambulatory ECG Recorder...
... ECG-9320 is a full-featured ECG ... IEC60601-2-51 new international standard for ... digital filter performance. The ECG ... managed on a Windows PC ...
... IEC60601-2-51 new international standard for digital ... performance. ECG data can be reviewed ... with the optional ECG Viewer software. ... in other countries, and it truly ...
... pHOx series consists of six analyzer models providing ... profiles. Measured tests include pH, PCO 2 , ... sodium, potassium, ionized calcium, chloride, glucose, and lactate. ... minute. Its space saving design provides the smallest ...
Medicine Products: